Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Ad.p53-DC vaccine |
| Trade Name | |
| Synonyms | INGN-225 |
| Drug Descriptions |
INGN-225 (Ad.p53-DC vaccine) is an adenoviral-p53 dendritic cell vaccine, which potentially induces a cytotoxic immune response against tumor cells over expressing Tp53 (PMID: 20420527). |
| DrugClasses | p53 Vaccine 5 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Ad.p53-DC vaccine | Ad.p53-DC vaccine | 1 | 0 |
| Ad.p53-DC vaccine + Indoximod | Ad.p53-DC vaccine Indoximod | 0 | 1 |
| Ad.p53-DC vaccine + Ipilimumab + Nivolumab | Ad.p53-DC vaccine Ipilimumab Nivolumab | 0 | 1 |